Oncotelic Therapeutics, Inc. Realized Investment Gains (Losses)
Oncotelic Therapeutics, Inc. (OTLC) reported Realized Investment Gains (Losses) of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2018-04-17
- Oncotelic Therapeutics, Inc. realized investment gains (losses) for the quarter ending 2017-03-31 was $0.00.
- Oncotelic Therapeutics, Inc. realized investment gains (losses) for fiscal 2016 was $0.00.
| Period end | Realized Investment Gains (Losses) | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 | ||
| 2016-12-31 | $0.00 10-K · filed 2018-04-17 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-02 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-06 |